Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
APC Ltd, an Irish pharmaceutical research and development company, is investing €25M and creating 120 jobs through the formation of a ‘Global Centre of Excellence for Vaccine and Advanced Therapeutic Research and Manufacturing’.
read more
Tuesday, February 01, 2022
Antiverse announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in identifying antibody candidates for a target of interest, with ...
read more
Pharma Tech Industries (PTI), the largest pharmaceutical contract manufacturer and packager of powder products in the world, has hired management veteran Anthony (Tony) Mitchell as its new President and Chief Operating Officer. In this position, Mr....
read more
Thursday, November 07, 2019
ANI Pharmaceuticals announced its partner Pii has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection.
read more
Tuesday, January 07, 2014
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services ("Sterling.") The ...
read more
Monday, November 22, 2021
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, ...
read more
Thursday, October 14, 2021
ANGUS Chemical Company announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO™ tromethamine buffers. ANGUS is the world's largest and only fully integrated original manufacturer of TRIS AMINO buffers, which are ...
read more
Tuesday, February 15, 2022
ANGUS Chemical Company, a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the expansion of its Sterlington, Louisiana manufacturing facility to include commercial production of...
read more
Wednesday, September 09, 2020
Brickell has the right to develop AnGes’ proprietary investigational adjuvanted plasmid DNA vaccine intended to prevent COVID-19.
read more
ANA and Quotient Sciences announced a partnership to support the manufacturing of ANA001 as a potential treatment for COVID-19.
read more
Friday, September 24, 2021
At Pfizer CentreOne we aspire to be the CDMO partner of choice. Over the last several years our team has been working to expand our development services offerings so we can truly be an end-to-end CDMO, from development through to commercial ...
read more
Thursday, February 25, 2021
Amyris announced promising preliminary data in a pre-clinical study of its RNA COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges.
read more
Friday, February 23, 2018
AMRI announced expansion of its industry-leading container closure integrity testing (CCIT) services into the European Union.
read more
AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) for $110 million in cash. OsoBio is recognized as a premier ...
read more
Tuesday, September 08, 2020
AMRI has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222.
read more